Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 209

    1.

    Fas deficiency prevents type 1 diabetes by inducing hyporesponsiveness in islet beta-cell-reactive T-cells.

    Vence L, Benoist C, Mathis D.

    Diabetes. 2004 Nov;53(11):2797-803.PMID: 15504959 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Significant role for Fas in the pathogenesis of autoimmune diabetes.

    Su X, Hu Q, Kristan JM, Costa C, Shen Y, Gero D, Matis LA, Wang Y.

    J Immunol. 2000 Mar 1;164(5):2523-32.PMID: 10679090 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.

    Redd S, Ginn S, Ross JM.

    Histochem J. 2002 Jan-Feb;34(1-2):1-12.PMID: 12365794 [PubMed - indexed for MEDLINE]Related articles

    4.

    Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice.

    Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N, Matsuzawa Y.

    J Exp Med. 1997 Aug 18;186(4):613-8.PMID: 9254659 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.

    Balasa B, Van Gunst K, Jung N, Balakrishna D, Santamaria P, Hanafusa T, Itoh N, Sarvetnick N.

    J Immunol. 2000 Sep 1;165(5):2841-9.PMID: 10946317 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.

    Suarez-Pinzon W, Sorensen O, Bleackley RC, Elliott JF, Rajotte RV, Rabinovitch A.

    Diabetes. 1999 Jan;48(1):21-8.PMID: 9892218 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.

    Kim S, Kim KA, Hwang DY, Lee TH, Kayagaki N, Yagita H, Lee MS.

    J Immunol. 2000 Mar 15;164(6):2931-6.PMID: 10706679 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.

    Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P.

    J Clin Invest. 2000 Feb;105(4):459-68.PMID: 10683375 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes.

    Höglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D.

    J Exp Med. 1999 Jan 18;189(2):331-9.PMID: 9892615 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.

    Thomas HE, Darwiche R, Corbett JA, Kay TW.

    J Immunol. 1999 Aug 1;163(3):1562-9.PMID: 10415060 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes.

    Nakayama M, Nagata M, Yasuda H, Arisawa K, Kotani R, Yamada K, Chowdhury SA, Chakrabarty S, Jin ZZ, Yagita H, Yokono K, Kasuga M.

    Diabetes. 2002 May;51(5):1391-7.PMID: 11978635 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Fas and Fas ligand immunoexpression in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.

    Reddy S, Ross JM.

    Ann N Y Acad Sci. 2003 Nov;1005:166-9.PMID: 14679052 [PubMed - indexed for MEDLINE]Related articles

    13.

    Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.

    Silva DG, Petrovsky N, Socha L, Slattery R, Gatenby P, Charlton B.

    J Immunol. 2003 May 15;170(10):4996-5002.PMID: 12734343 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.

    Pakala SV, Chivetta M, Kelly CB, Katz JD.

    J Exp Med. 1999 Apr 5;189(7):1053-62.PMID: 10190896 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.

    Amrani A, Verdaguer J, Anderson B, Utsugi T, Bou S, Santamaria P.

    J Clin Invest. 1999 Apr;103(8):1201-9.PMID: 10207172 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes.

    Kim YH, Kim S, Kim KA, Yagita H, Kayagaki N, Kim KW, Lee MS.

    Eur J Immunol. 1999 Feb;29(2):455-65.PMID: 10064061 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes.

    Apostolou I, Hao Z, Rajewsky K, von Boehmer H.

    J Exp Med. 2003 Oct 6;198(7):1103-6.PMID: 14530378 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    [Role of Fas, FasL in NOD insulitis]

    Cao JY, Wang H.

    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002 Oct;24(5):486-90. Chinese. PMID: 12905770 [PubMed - indexed for MEDLINE]Related articles

    19.

    Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes.

    Walter U, Franzke A, Sarukhan A, Zober C, von Boehmer H, Buer J, Lechner O.

    Eur J Immunol. 2000 Apr;30(4):1224-32. Erratum in: Eur J Immunol. 2003 Jul;33(7):2064. Frantzke A [corrected to Franzke A]. PMID: 10760812 [PubMed - indexed for MEDLINE]Related articles

    20.

    Fas is detectable on beta cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice.

    Darwiche R, Chong MM, Santamaria P, Thomas HE, Kay TW.

    J Immunol. 2003 Jun 15;170(12):6292-7.PMID: 12794162 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data